Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis - 09/08/11
Plan
This case report was investigator initiated. Financial support for the manuscript was provided by Amgen Inc and by Wyeth Research. The authors wish to thank Julia R. Gage for assistance in manuscript preparation. Conflicts of interest: Dr Yamauchi is on the Amgen speakers board and is a consultant and investigator for Amgen but owns no Amgen stock. Dr Lowe is on the Amgen speakers board but owns no Amgen stock. Reprints not available from the authors. |
Vol 54 - N° 3S2
P. S135-S138 - mars 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?